Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients

Classification of patients with rheumatoid arthritis (RA) as quickly as possible improves their prognosis. This reason motivates specially dedicated early arthritis (EA) clinics. Here, we have used 1062 EA patients with two years of follow-up to explore the value of anti-carbamylated protein (anti-C...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Rep
Autors principals: Regueiro, Cristina, Nuño, Laura, Ortiz, Ana M., Peiteado, Diana, Villalba, Alejandro, Pascual-Salcedo, Dora, Martínez-Feito, Ana, González-Alvaro, Isidoro, Balsa, Alejandro, González, Antonio
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5607236/
https://ncbi.nlm.nih.gov/pubmed/28931886
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-09657-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars